Concomitantly, the modified/oxidized and crosslinked TTR molecules may actively contribute to the pathogenesis of multiple sclerosis, either due to the lack of native TTR function or due to the switch of TTR from a protective [23] to a pathological component of the redox vicious cycle. This evidence concerns the gene TTR and multiple sclerosis.